TScan Therapeutics (TCRX) Net Equity Issued and Repurchased (2021 - 2023)
TScan Therapeutics (TCRX) posted quarterly Net Equity Issued and Repurchased of -$186000.0 for Q3 2023, down 196.37% quarter-over-quarter from $193000.0 in Q4 2022.
TScan Therapeutics (TCRX) Net Equity Issued and Repurchased (2021 - 2023) Analysis & Trends
TScan Therapeutics (TCRX) has reported Net Equity Issued and Repurchased for 3 consecutive years, with -$186000.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Net Equity Issued and Repurchased changed N/A year-over-year to -$186000.0; the TTM figure through Dec 2024 stood at -$186000.0 (down 2757.14% YoY), while the FY2024 annual figure was $33.1 million, down 21.89% from the prior year.
- Net Equity Issued and Repurchased fell to -$186000.0 in Q3 2023 per TCRX's latest filing, from $193000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $99.7 million in Q1 2021 and bottomed at -$186000.0 in Q3 2023.
- Historically, Net Equity Issued and Repurchased has averaged $33.2 million across 3 years, with a median of $193000.0 in 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | TScan Therapeutics | 100.62 Mn | 100.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -186,000.00 |
| Sep 30, 2023 | -186,000.00 |
| Dec 31, 2022 | 193,000.00 |
| Dec 31, 2022 | 193,000.00 |
| Mar 31, 2021 | 99.73 Mn |
| Mar 31, 2021 | 99.73 Mn |